InvestorsHub Logo
Followers 8
Posts 333
Boards Moderated 0
Alias Born 09/09/2009

Re: None

Monday, 02/21/2011 8:28:57 PM

Monday, February 21, 2011 8:28:57 PM

Post# of 9698
What is important here is that the company is being bought at .15 a share..... who cares if they have any clinical trials, products, sales, business at all.... Please refer to line one, .15 per outstanding share is what everyone should be focused on, not your concern on why!